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Abstract
Background: Patient reported outcome measures (PROMs) are increasingly being used to compare the
performance of health care providers. Our objectives were to determine the relative frequency of use of different
metrics that can be derived from PROMs, explore clinicians’ and patients’ views of the options available, and make
recommendations.
Methods: First a rapid review of the literature on metrics derived from two generic (EQ-5D and EQ-VAS) and three
disease-specific (Oxford Hip Score; Oxford Knee Score; Aberdeen Varicose Vein Questionnaire) PROMs was
conducted. Next, the findings of the literature review were mapped onto our typology of metrics to determine
their relative frequency of use, Finally, seven group meetings with surgical clinicians (n = 107) and six focus groups
with patients (n = 45) were held which were audio-taped, transcribed and analysed thematically.
Results: Only nine studies (9.3% of included papers) used metrics for comparing providers. These were derived
from using either the follow-up PROM score (n = 3) or the change in score as an outcome (n = 5), both adjusted for
pre-intervention score. There were no recorded uses of the proportion reaching a specified (‘good’) threshold and
only two studies used the proportion reaching a minimally important difference (MID).
Surgical clinicians wanted multiple outcomes, with most support expressed for the mean change in score,
perceiving it to be more interpretable; there was also some support for the MID. For patients it was apparent that
rather than the science behind these measures, the most important aspects were the use of language that would
make the metrics personally meaningful and linking the metric to a familiar scale.
Conclusions: For clinicians the recommended metrics are the mean change in score and the proportion achieving
a MID, both adjusted for pre-intervention score. Both need to be clearly described and explained. For patients we
recommend the proportion achieving a MID or proportion achieving a significant improvement in hip function,
both adjusted for pre-intervention score.
Background
There is increasing use of patient reported outcome mea-
sures (PROMs) to assess and compare the performance of
health care providers. Since April 2009, their use for meas-
uring the outcome of four common elective operations (hip
and knee replacement, hernia repair, varicose vein surgery),
using before and after data, has been mandatory in the
NHS in England. [1,2] Their use is likely to expand in the
future. It is envisaged that PROMs will help improve the
quality of care through several mechanisms: enhancing pa-
tient choice, encouraging clinicians and managers to review
patient care, informing commissioners' decisions and pro-
viding information for regulators. [3-5]
Although PROMs have been subjected to extensive test-
ing of their measurement properties, less attention has been
paid to the range of metrics that can be derived from
before and after PROMs data. Our aim was to recommend
the most appropriate metrics for comparison of the
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providers of surgery for presentation to clinicians and to
patients. To achieve this, the objectives were: to identify the
different metrics that can be derived from PROMs; to as-
sess the relative frequency with which these have appeared
in the literature; and to explore the views of clinicians and
patients of different metrics for comparing health care pro-
vider performance. Different formats for presenting such
data to lay and to clinical audiences, which will anchor the
choice of metric, have been reported elsewhere [6-8].
Methods
Literature review: Frequency of use of different types of
metrics
The review sought to identify which metrics had been
derived fromeach of the five PROMs used in the National
PROMs Programme and what their relative frequency of
use has been. The measures include: two generic (EQ-5D
and EQ-VAS) [9-11] and three disease-specific PROMs
(Aberdeen Varicose Vein Questionnaire (AVVQ) [12];
Oxford Hip Score (OHS) [13]; Oxford Knee Score (OKS)
[14]).
As the original conception of these instruments was to
measure treatment outcomes, we expected that most of
the literature would be evaluations of clinical interven-
tions rather than comparisons of providers. We there-
fore did not limit our search to the latter use. This
ensured that we would capture a wide range of metrics.
We conducted a ‘rapid review’ [15] of the literature
using systematic searching and screening methods to
produce a sample of literature that would give the range
and relative frequency of the metrics of interest. As we
were not aiming to provide a comprehensive account of
the total number of uses of each metric that had
appeared in the literature, a full systematic review was
deemed inappropriate.
The searching was conducted across seven databases,
hosted by the Ovid interface: EMBASE; Medliner; Global
Health; Health Management Information Consortium; Psy-
chInfo; PsychExtra; Social Policy and Practice. The search
string combined EQ-5D search terms with a set of terms
developed to capture measurement of change and longitu-
dinal studies. Only the EQ-5D required limiting in such a
way, as disease-specific PROMs have been used less fre-
quently so were sought using their names only. The full
search string was therefore: (EQ-5D terms AND change
measurement terms) OR (AVVQ terms or OKS terms or
OHS terms).
Expert recommendations for grey literature (i.e. not pub-
lished in a peer reviewed journal) or for literature currently
in press were asked for within our immediate team and
teams with overlapping research interests, and were
included for screening. Selection was carried out using
agreed criteria at title, abstract and full-text screening to
capture how the selected PROMs had been applied to
measuring change. The primary inclusion criterion was that
the paper reported change on at least two occasions, using
one of the included PROMs instruments. Full inclusion and
exclusion criteria are summarised in Table 1. The following
information was extracted from each paper: sample size;
number of health care providers; data collection time
points; number of outcome measures; methods of deter-
mining change in health status.
The typology was constructed around two criteria: the
type of outcome (a measure of post-intervention health
status or the extent of change in health status following
an intervention); and whether the metric was based on a
continuous variable (eg a mean score) or a categorical
variable (eg proportion achieving a defined outcome).
Our focus was on identifying frequencies with which
these types of metrics were currently used and on gener-
ating a shortlist of distinctive metrics appropriate for
comparing performance of healthcare providers. Full
statistical methods for routine comparisons of perform-
ance have been explored elsewhere [16].
Our selections were based on a pre-requisite for such
analyses, the potential for complex case-mix adjustment,
that is an outcome that could be included as a
dependent variable in a statistical model adjusting for
the impact of patient characteristics (eg linear or logis-
tic regression to account for socio-demographic, co-
morbidities, previous admissions). Metrics that could
not be adjusted or were only crudely adjusted (eg strati-
fication) in simple analyses were recorded but deemed
unsuitable for our purposes.
Four suitable metrics were selected (all would be
adjusted for pre-intervention score) to propose to clini-
cians and patients:
✓Mean follow-up score
✓Mean change in score
✓Proportion reaching a specified (‘good’) threshold at
follow-up
✓Proportion reaching a minimally important difference
(MID)
These were chosen to represent the range available from
our typology; although we recognise that some measure the
same thing (i.e. the mean follow-up and change score
would give identical rankings) [17]. And others, if accur-
ately and consistently derived, would likely produce the
same or very similar rankings (i.e. using a minimally im-
portant difference or a specified threshold for a ‘good’ out-
come in the follow-up score).
Qualitative study: Exploring clinician and patient views on
selected metrics
Views of selected metrics were elicited around accuracy
and interpretability. On accuracy we sought views on
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whether metrics successfully captured differences attrib-
utable to provider performance. On interpretability we
sought views on the meaningfulness of the proposed
metrics.
To obtain such views from surgical clinicians’ meetings
were held at six hospitals, supplemented with one meeting
at a national conference for clinical staff involved in
pre-operative assessment. Meetings took place between
September and December 2010. A pragmatic approach
to the setting, duration and attendance was adopted
given we had to fit in with clinicians’ limited availability.
The hospitals were selected from those that had partici-
pated in the Patient Outcomes in Surgery (POiS) Audit
given that those clinicians had demonstrated an interest in
the topic [18]. Seven meetings took place (N=107). Con-
sultants were present at all meetings, nurses or allied
health professionals at five meetings, and junior doctors at
four meetings (Table 2).
To obtain the views of patients, six focus groups were
undertaken between October and December 2010, hav-
ing obtained ethics approval from a Multicentre research
Ethics Committee. Arthritis Care (the leading patient
organisation for arthritis in the UK) identified 11 partici-
pants for the first focus group of whom eight agreed to
take part. Participants for the other five groups were
selected from those who had taken part in the POiS
Audit. Of the 376 people invited, 76 agreed to partici-
pate (20%). Selection was stratified by the surgical oper-
ation they had undergone, age (54 and under; 55–74; 75
and above), sex and index of multiple deprivation
(IMD). This resulted in 45 people attending five meet-
ings; including six partners or lay carers, in response to
requests from some patients (Table 3). Consent to par-
ticipate and for the discussions to be audio-taped was
obtained.
Meetings with clinicians and patients were facilitated
by one of the authors, accompanied by an observer who
took notes. Meetings with clinicians lasted about an
hour and with patients about one and a half hours. We
sought participants’ views not only of metrics that could
be derived from PROMs but also the format and content
of how to present data (reported elsewhere [7,8]). To aid
the discussions, the Oxford Hip Score was used as the
example of a PROM and the four different metrics were
explained using this instrument and illustrated in Power-
Point as depicted in Figure 1.
The recordings were transcribed verbatim. Data
from clinicians were independently analysed by NB
Table 2 Description of clinicians who participated in hospital meetings
Meeting Specialty Type of meeting
Profession
Consultant Junior
doctor
Nurse;
AHP*
Other**
A (N= 7) Orthopaedic surgery Clinical governance 4 3 - -
B (N= 17) Pre-operative assessment National conference session 5 - 10 2
C (N=7) General surgery Pre-arranged meeting 4 - 1 2
D (N= 30) Orthopaedic surgery Clinical governance meeting 5 16 9 -
E (N= 6) General surgery; Orthopaedic Pre-arranged meeting 2 - 4 -
F (N= 20) General surgery; Care of the
Elderly
Hospital wide teaching 4 16 - -
G (N= 20) Orthopaedic surgery Clinical governance 5 9 4 2
Totals (N= 107) All were surgical units Tagged to existing agendas or
specifically pre-arranged
29 44 28 6
*AHP=Allied Health Professional.
**Managers, administrators, IT staff, clinical audit staff.
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Uses one of five PROMs (EQ-5D on its own or supplemented by
EuroQol VAS; OHS; OKS; AVVQ) as a study outcome
Focus is not on using instruments but assessing if we should use them
at all (i.e. review of instruments, assessing psychometric properties,
reliability etc.)
Reports change in PROM at two or more time points:
At title screen: possible focus on included
instrument and measuring change.
At abstract screen: focus on included instrument and
measuring change.
At full-text screen: describes analyses of change using
included instrument
Focus is not on included instruments, these must be used as a study
outcome (i.e. EQ-5D used in QALY outcomes, and analyses using only
EuroQol VAS are excluded)
Peer reviewed and non-peer reviewed literature Published in foreign language and or no existing English translation
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and DA, data from patients by NB and ZH. Thematic
analyses (of first and second order concepts) on the
views of each metric were summarised with illustra-
tive quotes for each audience. Both sets of findings
were then reordered and interpreted (ZH and JN) in
a framework analysis that accounted for concepts of
accuracy and interpretability which had been identi-
fied as two core second order concepts across both
Figure 1 Metrics displays.
Table 3 Description of patient and other focus group participants
Group Sex Operation Age (years) Socio- Economic Status (IMD* quintiles) Not known
M F Hip Knee VVs none 40-55 56-75 >75 1 2 3 4 5 -
A (N = 8) 3 5 5 2 0 1 2 3 3 2 0 0 0 0 6
B (N = 7) 4 3 2 3 0 2 2 3 2 0 2 1 3 0 1
C (N = 6) 4 2 0 4 0 2 1 2 3 0 2 2 2 0 0
D (N = 8) 4 4 0 8 0 0 2 4 2 3 2 2 1 0 0
E (N = 9) 5 4 8 0 0 1 1 4 4 1 2 3 2 1 0
F (N = 7) 2 5 0 0 7 0 1 5 1 1 1 4 1 0 0
Totals (N= 45) 22 23 15 17 7 6 9 21 15 7 9 12 9 1 7
*Index of multiple deprivation, 1 least deprived to 5 most deprived, or NK = Not known.
VVs = varicose vein surgery.
A &B) London, C) Birmingham, D) Sheffield, E) Liverpool, F) Bournemouth.
Hildon et al. BMC Health Services Research 2012, 12:171 Page 4 of 13
http://www.biomedcentral.com/1472-6963/12/171
audiences. Paired analysis found a high level of inter-rater
agreement; where differences occurred, a consensus was
achieved through discussion.
Results
Literature review
Screening and selection
Literature searches carried out in March 2010 identified
439 potential papers. On title screening 67 duplicates
and 9 non-English language papers were removed, leav-
ing 363. Of these, 15 cited more than one PROM, thus
yielding 388 reported uses of the included measures. Ab-
stract screening led to 72% being excluded because they
did not use PROMs as a study outcome or did not re-
port on change in health status. A further seven papers
were excluded at full-text screening for the same rea-
sons, leaving 96 papers for analysis (Figure 2).
Descriptive information from included studies
Allowing for papers covering more than one measure,
the number reporting on each PROM was: EQ-5D 49,
EQ-VAS 18, AVVQ 8, OHS 32, OKS 17. About 20% of
studies used a single PROM; more commonly several
instruments were used, though some which are not
included in this review. Sample sizes ranged widely
(10 to 9430) with only around 10% having over 1000
cases. The number of time points across which PROMs
were collected ranged from two to eight, the mean being
two. The length of follow-up for most studies was 6–
12 months.
PROMs were used to compare services or health care
providers in only six studies [19-24]. Audiences for all
the included studies were clinicians, academics or
policy-makers. The most frequent use of PROMs was in
randomised (n = 29 papers) or non-randomised (n = 41)
evaluations of clinical or psycho-social interventions.
Other uses were to report differences in outcomes be-
tween patient groups (seven papers), variations in out-
comes within a specific population (n = 12 studies) or
change in people’s health status over time with no inter-
vention (one study).
Frequency of use of the different types of metrics
In terms of the typology of metrics, see Figure 3 grids A-J,
or the range of anticipated analyses and outcomes, the most
frequent metric was simple analyses that reported raw
follow-up means or medians, grid A, (n=76). These
averages were compared to pre-intervention averages, im-
plicitly assessing change. Explicit change outcomes in the
simple analyses were far fewer, grid B, with eight papers
reporting mean differences, and 11 using standardised
change outcomes (standardised effect sizes or response
means). The latter was used for comparing different instru-
ments on consistent scales.
Proportions (categorical outcomes) were also less fre-
quently used in the simple studies. No papers that fitted
our inclusion criteria reported on the proportion report-
ing a specified threshold (e.g.42 points on the OHS as a
desired outcome [24]), as represented by grid C. Five
studies, grid D, compared different ways of deriving
meaningful benchmarks in change scores based on min-
imally important differences (MIDs). [24-28].
Earlier studies referred to ‘minimally clinically important
difference’ (MCID) [29,30] and ‘minimally clinically import-
ant change’ (MCIC) [31]. MIDs can be determined in two
ways. The anchor-based method which uses retrospective
categorical reports of the success or failure of an interven-
tion (clinician reported initially but more recently patient
reported) to determine when a meaningful change occurs.
An example of a patient reported anchor would be report-
ing health as ‘good’ or ‘very good’ after surgery. The
distribution-based approach derives the MID by statistical
methods, most frequently using half a standard deviation
[25,32].
Although the stated long-term aim of the studies was to
identify the proportion of patients who achieved a MID
and thus help the ‘interpretability’ [31] of the data, most
simply evaluated and tested the best method of calculating
a MID. A simpler, although perhaps less meaningful way of
deriving a proportionate change, was reporting proportions
of patients that were worse, the same, or improved (grid E,
n=6).
Predominance of explicit change outcomes in complex
analyses
Only nine studies carried out analysis using complex case-
mix adjustment [24,26,27,33-38]. In marked contrast to the
simpler analyses, only three studies reported on using a
follow-up score, grid F. Most used the explicit change out-
come in some form. It appears that this outcome may be
easier to understand even though the pre-score is double
counted. Five complex analyses, grid G, used the change
score in a linear regression model. No studies specified a
threshold for the follow-up score, grid H. A couple of stud-
ies determining the MID using patient reported anchors,
grid I, chose to model these in outcomes in logistic regres-
sion. Only one paper, grid J, considered the proportion im-
provement, which was reported as arbitrarily selected.
Clinicians’ and patients’ views on selected metrics
While some patients expressed their views about the differ-
ent metrics, many found it hard to understand information
presented in a quantitative way:
From my point of view, you’re using a language I
don’t understand.
Ideal for a surgeon or hospital management or
whatever but for patients, no.
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To the ordinary man in the street, a lot of its
gobbledygook.
In contrast, many clinicians perceived each metric to
provide different information to such an extent that they
found it difficult to express a preference. They therefore
wanted more than one to be made available:
Why can’t we have all of them? I mean, we’re used to
reading papers and understanding data, and they all
tell you something slightly different.
They all look quite important, really. So, I expect if
you asked four different clinicians, they’ll say yes to
each of them.
Nevertheless, some clinicians were quick to dismiss
the options presented to them until they were satis-
fied that case-mix (characteristics of patients that
might affect the outcome of their care such as age,
comorbidity and severity) was adequately accounted
for, which we were quick to reassure them was part
of the analysis:
Figure 2 Searching and screening output.
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What I want is value added. I want it compared to
what we started from.
These issues also arose in the patient focus groups, but
not explicitly in relation to the different metrics; instead
they were expressed in terms of how we might account
for some hospitals starting with patients who were sicker
than they might be in other hospitals.
Apart from ‘all or nothing’ preferential statements, the
differences in the metrics were discussed in terms of their
perceived accuracy (justified or erroneous) in indicating
the performance or quality of providers and their inter-
pretability, or perceptions around how easy they were to
understand. The clinicians were far more vocal on accur-
acy than the patients, who cared more about interpretabil-
ity. Each metric (Mean follow-up; mean change in score;
proportion reaching a specified ‘good’ threshold at follow-
up; and proportion reaching a minimally important differ-
ence (MID) will be considered in turn relative to these
concepts.
Mean follow-up score
Accuracy
Clinicians voiced concerns about the accuracy of the
mean follow-up score, questioning whether a mean
Figure 3 Typology of metrics using before and after PROMs data; highlighted grids were selected for exploring in the clinician
meetings and patient focus groups.
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score would be sensitive enough to detecting change
over time:
An improvement in that average might not be
possible over quite a few years. Even putting in a great
effort, you’ll never show an improvement when you’ve
got an average.
A related concern expressed by this audience was that
the metric was not transparent enough about the degree of
dispersion of individual patient scores to accurately portray
performance:
You’ve got no concept of what your range is. . .your
spread could be enormous or could be really tight.
That really matters because you may be making some
people worse but if you’re making enough people
really good, your mean’s going to be okay.
Patients similarly talked about lack of information on in-
dividual variation using this measure, questioning whether
this metric may be too subjective to accurately capture per-
formance:
Everybody’s sense of pain is different, so you can’t say
that one person’s average is another person’s good. . .
Some days it’s 20, some days it’s 40 [points].
This criticism of the metric, also levelled by clinicians
at the other continuous metric (change outcome), was
interesting because it is no less true of the metrics using
categorical outcomes or proportions. Since the unit of
analysis is the hospital rather than the patient, outcomes
for all proposed metrics would be aggregated at the
patient level. Yet both audiences did not think this
was a problem with the logistic models presented as
proportions.
Interpretability
Nevertheless, there was support among some clinicians
for the interpretability of mean follow-up score. It was
thought to be straightforward and likely to influence
clinical practice:
If you present data like this people are going to use
it. . . The main things you’re going to use this for are
for the [surgical] department itself to monitor changes
within the department.
It was however clear from the discussion surrounding
the change score metric (see below), that some clinicians
did not recognise that the mean follow-up score was an
implicit measure of change; and would give the same
results as the explicit measure, given that the pre-
intervention score featured in both models.
Patients, on the other hand, did not raise issues to
do with explicitly measuring change, but struggled to
make sense of what a particular score meant in
terms of symptoms and disability:
Points mean nothing to me. . . So, before my
operation I thought “Where would I like to go to
afterwards to get better?” Now, if you could relate
from my point of view to my objective, then you’re
going somewhere. But if you talk points I’m almost
switching off.
These comments were often followed by championing
the virtues and universality of the percentage, or a 1–10
scale.
Mean change in score
Accuracy
Many clinicians preferred the mean change to the mean
follow-up score. The former was seen as more accurate;
since it explicitly took account of the pre-operative
score, despite both metrics adjusting for this:
Change in score is far more useful than an average
post-op score. . .[which] is completely related to where
they start and so I don’t believe you could fully take
account what it was. So somebody starting with 24
and getting to 48, the fact that they’ve improved by 24
is far more important than. . .the average [follow-up
score].
The lack of understanding around case-mix adjust-
ment was also seen to render the mean change score po-
tentially less accurate as a measure of performance,
because it would favour providers whose patients who
had greater scope to improve:
A change in the score is probably going to favour our
work because, statistically, our work base is actually
older and more severely diseased than most other
units.
It’s a bit like Ryanair being the most improved airline
of the year. . . It’s the baseline level, isn’t it? We need
to know what the baseline is before you can assess
whether the average change has been important or
not.
Another concern from clinicians was whether individ-
ual level change was accurately captured. It was not
envisaged that clinicians would be misled; instead the
problem was projected onto patients:
Hildon et al. BMC Health Services Research 2012, 12:171 Page 8 of 13
http://www.biomedcentral.com/1472-6963/12/171
What Joe Public won’t know is, is this average change
starting from 42 and going to 52 or is it an average
change of ten points from 20 points to 30? So in fact,
although they’ve got a ten point average change,
which suggests it’s a good improvement, they may be
going from poor to still less than good, whereas
somewhere else might be going from very good to
excellent.
Patients however, had little comment to pass of the ac-
curacy of this metric.
Interpretability
Clinicians, on the whole liked the explicit use of a
change metric, finding it meaningful and intuitive, even
using the continuous score:
The change is much more important than a fixed
number you’re trying to get people to get to or their
point in time score
Except that, as with the post-operative adjusted metric,
patients were unclear what the actual change score
meant in terms of improvement in symptoms and
disability:
Patient A: Eight points. Eight points of what? If all I felt
was 8% better I wouldn’t bother to do it unless I was
going to die from it. They don’t mean a thing to me.
Patient B: That’s right, isn’t it, eight points of what?
Patient A: You haven’t told anybody what the points
are.
Patients in many ways preferred an outcome to be
defined in terms of an experience rather than a number.
Proportion reaching a specified (‘good’) threshold
Accuracy
The accuracy of using the proportion reaching a speci-
fied (‘good’) threshold in follow-up score, as a perform-
ance indicator, was questioned by clinicians. First, they
noted that some patients who would never be able to
reach the threshold may still have benefited from sur-
gery:
[Proportion above threshold] is rubbish, I think,
because you don’t know what they start off with. . . if
they come in paralysed from the neck down and you
actually enable them to sit up by their own without
outside help, then it’s an absolute miracle. . . You have
to know the starting point.
I did somebody yesterday who’s never going to get to
the [threshold] but, actually, considering she started
off like this, just getting her sitting up and being able
to take five steps with her frame is going to be a huge
success for her.
Second, there was concern as to how a threshold for
‘good’ outcome would be determined:
You’d probably have to be a bit more specific about
what [the threshold score] means.
Can I just say that 42 and over, I think that’s
exceptionally high to give a good hip function score.
We’ve got a lot of patients who come back with a
score of 32, 33, they’re exceptionally happy with the
outcome of their surgery.
Although to date clinical appraisal has been used to
select the appropriate thresholds [39], it is more fitting
that patient reports be used to inform appropriate
thresholds in PROMs analyses.
Interpretability
The proportion reaching a specified threshold, along
with the proportion of patients achieving a MID (see
below), was perceived by clinicians to be easier for
patients, for instance, to interpret over time. The speci-
fied threshold was also the metric seen to be the patients
favourite:
These [the proportion over a threshold and
proportion with MID] are much more likely to be of
benefit to patients because I think they’re easier to
understand and you’ll be able to show year-on-year
improvement or some solution to a perceived
problem much more easily.
I’d choose that one [proportion over a threshold]
because it’s – to me it’s the most important thing that
the patients are interested in.
Patients confirmed this, finding it easier to grasp than
mean scores:
The proportion of patients achieving good hip
function tells us something about the success and
failure of the number of operations that’s being
carried out.
I think that 62% is a good number to latch onto,
whereas if you’ve got a point score, peoples’ points
out [of however many] are quite different. Whereas if
62% says, “Look, I really feel pretty good”. . .
The percentages sign, once again, winning this audience
over.
Proportion reaching a minimally important difference
(MID)
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Accuracy
Despite much support, there were also some concerns
expressed by clinicians about the accuracy of using a MID
as a performance indicator. They suggested that the value
of a MID would depend on a patient’s starting point,
which was not taken into account:
[This metric] doesn’t account for non-linearity of the
scale. In other words, eight points might be not
important at 30 but very important at 40.
They also perceived a potential difficulty in defining
what constitutes a MID though assumed it would be
decided by clinicians rather than using anchor-based
(patient reports) or statistical methods:
The problem. . .is you have to establish what’s a
minimally acceptable difference. And I suspect we’ll
all argue about that. Whereas if you just go for the
change we’re achieving, it’s not so debatable.
Their other concern was that, by definition, this metric
assessed providers in terms of a minimum standard ra-
ther than something more demanding:
If I, as a patient, had an eight point improvement,
well, what does that mean compared to the normal
improvement that one would expect from that
operation? So am I scoring eight points, when really I
should be getting 15.
It was also noted (erroneously) by one clinician that
unlike achieving a specified threshold in the follow-up
score, using the MID metric would not put providers
who operated on more severe patients at a disadvantage:
They may have a population of people living there
who are all 97 and are all crocked or whatever, or
start with a very low baseline anyway, that’s just the
way they are. You’re still improving their lives by
taking them from one to ten.
A lot of assumptions were made about the MID, per-
haps because this one of the more complex metrics to
derive. Interestingly, this aspect of the measure was not
criticised, nor did the clinicians appear phased by expla-
nations of the MID.
Interpretability
Clinicians argued that despite some drawbacks around
accuracy the proportion reaching a MID would be one of
the most interpretable metrics, particularly to patients:
This minimally important difference is clearly what’s
important to patients because. . .it relates to them
doesn’t it, not to us? So that would be my favourite
one.
From the patient’s point of view, what they want is an
improvement in, presumably, pain and function, so
that’s the one that defines that most accurately, I
think.
However, some of the support for this metric may have
been based on confusing it with the previous one,
achieving a threshold:
The minimally important difference is going to be the
threshold, isn’t it? It’s going to be that proportion of
patients who can walk with no pain versus those that
walk with a bit of pain.
Patients’ interest in this metric was indeed confirmed
with the concept of a MID or ‘significant’ improvement
being readily interpretable:
In my case, there was a very significant improvement.
I was absolutely hopeless before. . .I’ve always been
really athletically inclined as it were and the people
around me are all involved in a club atmosphere, and
they noticed that prior I just went sort of down the
hill as it were. When I came back I was back up the
top of the hill again. So in that respect, the significant
difference was that.
If you knew. . .a change of five points was not very
significant, but a change of eight to ten was more
significant. . . If you knew that before you started, that
would be more meaningful.
A criticism often levelled at this metric and anchor
based methods of deriving it is that it relies on a single
item categorical measure of change, which may itself be
imperfect [40]. This issue was not raised by either of the
audiences we that we talked to.
Discussion
Main findings
The literature review found that the explicit change out-
come was the most frequently used. In the audiences of
interest to us, both clinicians and patients initially
struggled to make a selection when presented with a
choice of metrics, though for different reasons. Clini-
cians wanted variety, as they perceived that most of the
metric provided something of value and interest.
Patients at times could not distinguish between the four
options, but liked a percentage, or what was for them in-
tuitive scaling.
Metrics were either considered in terms of interpret-
ability and or scope of accuracy in capturing useful in-
formation; views on accuracy did not always match with
views on interpretability, and vice versa, see Figure 4. In
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terms of accuracy, both the metrics based on continuous
scores were seen by clinicians as limited in the scope of
variation that they allowed to discern; this was not
however unique to these metrics, but to the analyses,
and applied equally to the categorical or dichotomous
metrics. In addition, both patients and clinicians ques-
tioned whether continuous outcomes would be able to re-
port actual ‘improvement’ in the quality of care, which
was necessarily required to evaluate performance; it was
clear from these queries that the adjusted follow-up out-
come was not readily identified as an implicit measure of
change.
This said some clinicians identified this metric as the
most straightforward measure, quickly grasping the scor-
ing; for patients on the other hand, unlike measures of
height or weight, PROMs scores are unfamiliar and their
values have no immediate meaning. It’s therefore neces-
sary to transform them into interpretable forms, or in-
deed into experiences rather than metrics, to make them
useful. The language used to express the MID seemed to
resonate with patients because it captured something of
the patient experience. Clinicians echoed the patient en-
dorsement of categories of change, spotting that these
that these would be most interpretable to the public.
Categories were seen as easy to understand and sensitive
to improvements in performance. However, for clinicians,
there were also reservations. They argued that depending
on where a threshold was set, the use of this metric might
fail to acknowledge the benefit patients would gain from
moving from a very severe to a moderately severe condi-
tion. In terms of accuracy, therefore the preference was for
the using the MIDs despite some concern that this metric
only assessed whether a provider was achieving a minimum
level of care. The other concerns were methodological: how
a threshold or MID would be defined and how non-
linearity would be managed.
Limitations
Given the paucity of literature on comparing provider
performance, the review depended on extrapolating from
analyses using PROMs in other types of comparison.
This nevertheless allowed for consideration of habitual
use of these data giving insight into how clinical audi-
ences at least might generally expect to see them used.
For the qualitative studies, we selected participants
from those that had volunteered to take part in the earl-
ier POiS Audit. Our sample of surgical clinicians may
not, therefore, be representative of the views of all such
Figure 4 Clinician and patient views of accuracy and interpretability of the four selected metrics.
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clinicians but be biased towards those who are more
supportive of the use of PROMs. In addition, this study
has been limited to the use of PROMs in surgery and,
therefore, to the views of surgical clinicians. Clinicians
in other areas of health care may hold different views. It
was not possible to control the number of attendees,
duration and room layout. This made some of the
groups quite large and, inevitably, not everyone partici-
pated in the discussions.
The heterogeneity of professions and grades that
attended the meetings may have affected the views
people were prepared to express (e.g. concern about
the opinions of peers). It was reassuring that, as
regards the medical staff, junior doctors participated
as much as their senior colleagues. Although non-
medical clinicians attended, they made few contribu-
tions such that the majority of the views expressed
were those of doctors.
As regards patients, most participants had recently
undergone surgery so their views may not therefore rep-
resent those of people who are still to make a choice of
provider. In addition, their views will have been influ-
enced by their personal experiences of surgery. Whilst
representative of patients in terms of age and sex, people
from the poorest socio-economic group were under-
represented, which may mean that our sample were also
more educated.
Conclusions
Although there was a lack of unanimity both among clini-
cians and patients as to the best metric policy-makers
should choose, a decision has to be made as to which
options would be best for dissemination to each audience.
Lack of unanimity does not mean there was no discernable
consensus. In addition, the discussions helped us to glean
how best to explain the metrics in written instructions and
labelling, and how to clarify common misunderstandings.
These included the use of standard colours, consistent dir-
ection of ranking (from best to worst) and clear explana-
tions of concepts such as confidence intervals.
For clinicians, in response to requests for multiple
metrics we recommend a categorical and a continuous
outcome be used. The mean change in score (adjusted
for pre-intervention score) was the most readily grasped.
Although some confusion around case-mix would need
clarifying, these issues may be easier to address than
conveying the implicit change measurement conferred
by the mean follow-up metric. Similarly, we recommend
using the MID as a dichotomous outcome, and clearly
outlining the methodology by which it was derived.
For patients it was apparent that rather than the sci-
ence behind these measures, the most important aspect
of clearly relaying them was using language that would
make the metrics personally meaningful and linking
these to familiar scaling. For this audience, therefore we
propose using the proportion achieving a MID (adjusted
for pre-intervention score) or ‘proportion achieving a
significant improvement in hip function’.
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